135 related articles for article (PubMed ID: 22012715)
1. Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2.
Ryu HJ; Kim DY; Park JY; Chang HY; Lee MH; Han KH; Chon CY; Ahn SH
J Med Virol; 2011 Dec; 83(12):2088-95. PubMed ID: 22012715
[TBL] [Abstract][Full Text] [Related]
2. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
Chen BF
World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
[TBL] [Abstract][Full Text] [Related]
3. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
[TBL] [Abstract][Full Text] [Related]
4. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
Li GJ; Harrison TJ; Yang JY; Chen QY; Wang XY; Fang ZL
Liver Int; 2013 Jul; 33(6):936-43. PubMed ID: 23517325
[TBL] [Abstract][Full Text] [Related]
5. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter].
Tan YW; Zhang YH; Jiang WJ; Xing MY; Man XB; Mao JZ; Ge GH; Wu CS; Zhu MQ; Xu J; Sun L; Zhou XP
Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):679-83. PubMed ID: 24160343
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.
Kao JH; Liu CJ; Jow GM; Chen PJ; Chen DS; Chen BF
Liver Int; 2012 Oct; 32(9):1373-81. PubMed ID: 22676233
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
[TBL] [Abstract][Full Text] [Related]
10. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
[TBL] [Abstract][Full Text] [Related]
11. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
12. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma.
Yeh CT; So M; Ng J; Yang HW; Chang ML; Lai MW; Chen TC; Lin CY; Yeh TS; Lee WC
Hepatology; 2010 Dec; 52(6):1922-33. PubMed ID: 20814897
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection.
Choi MS; Kim DY; Lee DH; Lee JH; Koh KC; Paik SW; Rhee JC; Yoo BC
J Viral Hepat; 2007 Mar; 14(3):161-8. PubMed ID: 17305881
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
Araujo OC; Barros JJ; do Ó KM; Nabuco LC; Luz CA; Perez RM; Niel C; Villela-Nogueira CA; Araujo NM
J Med Virol; 2014 Feb; 86(2):217-23. PubMed ID: 24338810
[TBL] [Abstract][Full Text] [Related]
18. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.
Ochwoto M; Chauhan R; Gopalakrishnan D; Chen CY; Ng'ang'a Z; Okoth F; Kioko H; Kimotho J; Kaiguri P; Kramvis A
Infect Genet Evol; 2013 Dec; 20():103-10. PubMed ID: 23978387
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.
Lyu H; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ
J Viral Hepat; 2013 Mar; 20(3):219-24. PubMed ID: 23383661
[TBL] [Abstract][Full Text] [Related]
20. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM
Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]